ADULT VACCINES MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global adult vaccines market with an estimated market share of 40.2% in 2024. The presence of major vaccine manufacturers and favorable government policies can drive the market growth. The U.S. accounts for the major share due to initiatives by CDC and FDA to promote immunization programs. Established healthcare infrastructure and high awareness among individuals for preventive healthcare boosts vaccine adoption.

The Asia Pacific region has emerged as the fastest growing market for adult vaccines globally. Countries like India, China and Japan are high potential markets due to their huge population bases and improving healthcare landscapes. Rising income levels have also increased affordability of vaccines in the region. Various initiatives by governments to increase immunization rates can also drive the market growth. For instance, the Indian government aims to eliminate vaccine-preventable diseases through universal immunization under 'Mission Indradhanush'.

Among exporters, North American countries such as the U.S. contribute significantly to global supplies due to their export focused major manufacturers. However, regional players from India and China have increased their exports footprint in recent times leveraging their large production capacities and competitive pricing of vaccines. Countries in Asia Pacific and Latin America primarily import adult vaccines to meet the demand-supply gap due to limited indigenous manufacturing capabilities. Cross-border trade of adult vaccines is driven majorly by tenders from United Nations agency procurement as well as regional governments and private organizations.